Nanjing Chia-tai Tianqing Pharmaceutical

This study tests an experimental capsule called NTQ5082 in 24 adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease where red blood cells break apart. The drug blocks a part of the immune system to stop red blood cell destruction. The goal is to see if it sa…

This early-stage study tests the safety of a new drug called NTB003 in 40 healthy adults aged 25 to 45. Participants receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat any …